48 results
Cyclacel (NASDAQ: CYCC ) is getting in gear to expand its capital base. The company is floating a new issue of common stock in an underwritten public offering. Just under 6.67 million shares of the firm will be sold at a price of $3.00 apiece. Additionally ...The Motley Fool · ByEric Volkman · 5/16/2013
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) (Cyclacel or the Company), today announced the pricing of the underwritten offering of 6,666,667 shares of its common stock at a price to the public of $3.00 per share. Cyclacel has …StreetInsider · 5/16/2013
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) announced that it is offering to sell, subject to market and other conditions, shares of its common stock in an underwritten offering. Cyclacel also expects to grant the underwriters a 30-day ...StreetInsider · 5/15/2013
NPS Pharmaceuticals, Inc.(NASDAQ:NPSP) shares gained 5.90% to $15.79. The company on May 28 reported that it has closed its recently announced public offering of common stock. The total number of shares sold was 6,900,000, comprised of 6,000 …cogonews.com · 5/29/2013
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) stock dropped 13.54% to $3. The company on May 16 announced the pricing of the underwritten offering of 6,666,667 shares of its common stock at a price to the public of $3.00 per share. Cyclacel has …SBWire · 5/17/2013
CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), today announced that it is offering to sell, subject to market and other conditions, shares of its common stock in an underwritten offering. Cyclacel also expects to grant the underwriters a 30-day ...Reuters · 5/15/2013
CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), today announced the pricing of the underwritten offering of 6,666,667 shares of its common stock at a price to the public of $3.00 per share. Cyclacel has granted the underwriters a 30-day option to …GlobeNewsWire (press release) · 5/16/2013
Cyclacel Pharmaceuticals (NASDAQ: CYCC) posted its quarterly earnings results on Monday. The company reported ($1.18) EPS for the quarter, Stock Ratings Network.com reports. Shares of Cyclacel Pharmaceuticals (NASDAQ: CYCC) traded down 3.Daily Political · ByPatrick Bannon · 5/13/2013
OMER closed Tuesday's trading at $4.03, down 2.18%. Oxygen Biotherapeutics Inc. ( OXBT) is all set to begin enrolling patients in the second cohort of its phase IIb clinical trial to investigate the safety and tolerability of Oxycyte in patients with ...NASDAQ · 4/30/2013
Find out if (CYCC) is in Cramer's Portfolio. On 4/17/13, Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock (CYCCP) will trade ex-dividend, for its quarterly dividend of $0.15, payable on 5/1/13. As a percentage of CYCCP ...TheStreet.com · 4/16/2013
You might also like
- © 2013 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback